A haplotype of angiotensin receptor type 1 associated with human hypertension increases blood pressure in transgenic mice

Journal of Biological Chemistry

Volumn 288, Issue 52, 2013, Pages 37048-37056

  Jain, Sudhir ^a   Prater, Alicia ^a   Pandey, Varunkumar ^a   Rana, Anita ^a   Puri, Nitin ^a   Kumar, Ashok ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC PREDISPOSITION; HAPLOTYPES; LINKAGE DISEQUILIBRIUM; OVER-EXPRESSION; PATHOPHYSIOLOGICAL; TRANSGENIC MICE;

MAMMALS;

BLOOD PRESSURE;

ANGIOTENSIN 1 RECEPTOR; C REACTIVE PROTEIN; INTERLEUKIN 6; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; UPSTREAM STIMULATORY FACTOR 2;

ADULT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA FLANKING REGION; FEMALE; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERTENSION; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE;

EID: 84891403901     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.520023     Document Type: Article

References (32)

1. Galis, Z. S., Thrasher, T., Reid, D. M., Stanley, D. V., and Oh, Y. S. (2013) Investing in high blood pressure research. A National Institutes of Health perspective. Hypertension 61, 757-761
2. Griendling, K. K., Murphy, T. J., and Alexander, R. W. (1993) Molecular biology of the renin-angiotensin system. Circulation 87, 1816-1828
3. Griendling, K. K., Ushio-Fukai, M., Lassègue, B., and Alexander, R. W. (1997) Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29, 366-373
4. Peach, M. J., and Dostal, D. E. (1990) The angiotensin II receptor and the actions of angiotensin II. J. Cardiovasc. Pharmacol. 16, (Suppl. 4) S25-S30
5. Mendelsohn, F. A. (1985) Localization and properties of angiotensin receptors. J. Hypertens. 3, 307-316
6. Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., and Smith, R. D. (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45, 205-251
7. Ito, M., Oliverio, M. I., Mannon, P. J., Best, C. F., Maeda, N., Smithies, O., and Coffman, T. M. (1995) Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. U.S.A. 92, 3521-3525
8. Le, T. H., Kim, H. S., Allen, A. M., Spurney, R. F., Smithies, O., and Coffman, T. M. (2003) Physiological impact of increased expression of the AT1 angiotensin receptor. Hypertension 42, 507-514
9. Hein, L., Stevens, M. E., Barsh, G. S., Pratt, R. E., Kobilka, B. K., and Dzau, V. J. (1997) Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc. Natl. Acad. Sci. U.S.A. 94, 6391-6396
10. Paradis, P., Dali-Youcef, N., Paradis, F. W., Thibault, G., and Nemer, M. (2000) Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc. Natl. Acad. Sci. U.S.A. 97, 931-936
11. Veerasingham, S. J., and Raizada, M. K. (2003) Brain renin-angiotensin system dysfunction in hypertension. Recent advances and perspectives. Br. J. Pharmacol. 139, 191-202
12. Gutkind, J. S., Kurihara, M., and Saavedra, J. M. (1988) Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats. Am. J. Physiol. 255, H646-H650
13. Perola, M., Kainulainen, K., Pajukanta, P., Terwilliger, J. D., Hiekkalinna, T., Ellonen, P., Kaprio, J., Koskenvuo, M., Kontula, K., and Peltonen, L. (2000) Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J. Hypertens. 18, 1579-1585
14. Kainulainen, K., Perola, M., Terwilliger, J., Kaprio, J., Koskenvuo, M., Syvänen, A. C., Vartiainen, E., Peltonen, L., and Kontula, K. (1999) Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33, 844-849
15. Bonnardeaux, A., Davies, E., Jeunemaitre, X., Féry, I., Charru, A., Clauser, E., Tiret, L., Cambien, F., Corvol, P., and Soubrier, F. (1994) Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24, 63-69
16. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Accurate transcription initiation byRNApolymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489
17. Warming, S., Costantino, N., Court DL, Jenkins, N. A., and Copeland, N. G. (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33, e36
18. Jain, S., Tillinger, A., Mopidevi, B., Pandey, V. G., Chauhan, C. K., Fiering, S. N., Warming, S., and Kumar, A. (2010) Transgenic mice with -6A haplotype of the human angiotensinogen gene have increased blood pressure compared with -6G haplotype. J. Biol. Chem. 285, 41172-41186
19. D'haene, B., Vandesompele, J., and Hellemans, J. (2010) Accurate and objective copy number profiling using real-time quantitative PCR. Methods 50, 262-270
20. Butz, G. M., and Davisson, R. L. (2001) Long-term telemetric measurement of cardiovascular parameters in awake mice. A physiological genomics tool. Physiol. Genomics 5, 89-97
21. Bird, I. M., Mason, J. I., and Rainey, W. E. (1994) Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology 134, 2468-2474
22. Massari, M. E., and Murre, C. (2000) Helix-loop-helix proteins. Regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429-440
23. Sawadogo, M., and Roeder, R. G. (1985) Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 43, 165-175
24. Sawadogo, M. (1988) Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF. J. Biol. Chem. 263, 11994-12001
25. Sirito, M., Lin, Q., Maity, T., and Sawadogo, M. (1994) Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res. 22, 427-433
26. Vallet, V. S., Casado, M., Henrion, A. A., Bucchini, D., Raymondjean, M., Kahn, A., and Vaulont, S. (1998) Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J. Biol. Chem. 273, 20175-20179
27. Wu, S., Mar-Heyming, R., Dugum, E. Z., Kolaitis, N. A., Qi, H., Pajukanta, P., Castellani, L. W., Lusis, A. J., and Drake, T. A. (2010) Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice. Hum. Mol. Genet. 19, 597-608
28. Ewens, K. G., George, R. A., Sharma, K., Ziyadeh, F. N., and Spielman, R. S. (2005) Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 54, 3305-3318
29. Zhao, Y. Y., Zhou, J., Narayanan, C. S., Cui, Y., and Kumar, A. (1999) Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 33, 108-115
30. Dickson, M. E., Tian, X., Liu, X., Davis, D. R., and Sigmund, C. D. (2008) Upstream stimulatory factor is required for human angiotensinogen expression and differential regulation by the A-20C polymorphism. Circ. Res. 103, 940-947
31. Szalai, A. J., Wu, J., Lange, E. M., McCrory, M. A., Langefeld, C. D., Williams, A., Zakharkin, S. O., George, V., Allison, D. B., Cooper, G. S., Xie, F., Fan, Z., Edberg, J. C., and Kimberly, R. P. (2005) Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J. Mol. Med. 83, 440-447
32. Mehta, P. K., and Griendling, K. K. (2007) Angiotensin II cell signaling. Physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292, C82-C97